Results 181 to 190 of about 143,471 (289)
The Expanding Clinical and Genetic Spectrum of Muscle Glycogen Storage Disease 0, (GSD0B)
ABSTRACT Glycogen storage disorders are a group of genetic disorders affecting glucose homeostasis in the body. Muscular glycogen stores are essential for liberating glucose for energy supply during bursts of activity and sustained muscle work. Muscle glycogen storage disease 0 (GSD0B) is associated with biallelic variants in GYS1 causing muscular ...
Sarah Donoghue+16 more
wiley +1 more source
H3CP contributes to sustainable synthesis by integrating regioselective enzymatic halogenation, Pd‐catalyzed Heck coupling, and enzymatic hydrolysis. TPGS‐705‐M micelles enable the Pd‐catalyzed step, allowing seamless compatibility with enzymatic reactions in one vessel under aqueous conditions.
Ran Zhu+3 more
wiley +2 more sources
Exploring the Use of Mobile Health Applications in Palestinian Community Pharmacy Practice. [PDF]
Nouri A.
europepmc +1 more source
Engaging Communities: Academic Pharmacy Addressing Unmet Public Health Needs: Report of the 2004–05 Argus Commission [PDF]
Robert E. Smith+5 more
openalex +1 more source
ABSTRACT The missense SNP NC_000004.12:g.102267552C>T (also known as SLC39A8.p.(Ala391Thr), rs13107325) in SLC39A8 encodes a zinc transporter. This SNP has been linked to schizophrenia and is the likely causal variant for one of the genome‐wide association loci associated with the disorder. Using regression analyses, we tested whether the schizophrenia‐
Sophie E. Smart+12 more
wiley +1 more source
Involvement of community pharmacy pharmacists in fecal immunochemical test screening without government support in Japan. [PDF]
Jin'o Y+4 more
europepmc +1 more source
Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? [PDF]
Janie Sheridan+2 more
openalex +1 more source
Objective Elezanumab is a monoclonal antibody that binds repulsive guidance molecule a (RGMa), an inhibitor of central nervous system regeneration after inflammation or injury. The aim was to assess the safety and efficacy of elezanumab in relapsing and progressive forms of multiple sclerosis (MS).
Bruce A.C. Cree+6 more
wiley +1 more source
Engaging community pharmacy in tuberculosis case detection (ENHANCE): a study protocol for an implementation study in Indonesia. [PDF]
Pradipta IS+9 more
europepmc +1 more source